Report structuring
Uploaded blood reports are transformed into structured biomarker records for review.
Sentinel Architecture
Sentinel Architecture
How Exia Bio structures biomarker intelligence, AI support, and controlled digital delivery without exposing public checkout or diagnostic claims.
Report reality before Sentinel
Existing blood reports arrive with different formats, marker sets, lab conventions, and missing advanced signals. Sentinel starts by structuring this source context before any educational output is produced.
Illustrative report-context visual — not a Sentinel dashboard, customer interface, or final delivered report.
AI-native Workflow
AI is part of the product workflow, not just a marketing label.
The AI layer supports report structuring, data normalization, missing-marker detection, and dashboard preparation. The Sentinel logic layer then organizes biomarker signals into pathway-specific output.
Biomarker normalization
Different report formats are converted into consistent internal records.
Missing-marker detection
The system identifies gaps that limit confidence or require targeted follow-up.
Dashboard generation
Pathway logic and biomarker maps are prepared into dashboard-ready output.
Platform Architecture
A controlled pathway from uploaded report to dashboard release.
This page is intended for high-intent users, partners, and technical reviewers who want to understand how Exia Bio is structured as a repeatable digital product.
01 · Intake
Report and context
User submits report data, pathway selection, and relevant intake context.
02 · Structure
Clean biomarker records
Values, units, dates, and reference intervals are converted into structured records.
03 · Interpret
Sentinel logic layer
Biomarkers are mapped into friction zones, missing signals, and pathway priorities.
04 · Deliver
Secure dashboard
Users receive a dashboard output designed for follow-up and future comparison.
Evidence-to-output logic
Dashboard, logic, and product-ready output.
Exia Bio is not presented as a consulting concept. The product is built around a repeatable workflow: uploaded report, structured data, biomarker logic, and dashboard delivery.
Evidence-to-output logic
01 · Report data
Existing lab values and marker availability
02 · Marker structuring
Tier 1 / Tier 2 grouping and missing-signal checks
03 · Confidence limits
What Sentinel can explain, and what remains incomplete
04 · Pathway calibration
Executive Performance, Training & Recovery, Metabolic & Body Composition, Longevity & Resilience, or System Awareness
05 · Output modules
Data clarity, performance zones, missing signals, and next priorities
Architecture view — internal report-to-output flow, not a dashboard screenshot.
Dashboard Output
Current dashboard output preview showing Sentinel Index, constraint classification, and friction-zone logic.
Release Boundary
The platform remains non-diagnostic and educational. Where a result appears outside the context Exia Bio is designed to explain, users are directed to share their original laboratory report and Exia Bio dashboard with a licensed healthcare professional.
Operating model
Built locally for controlled SG/MY deployment
Exia Bio is being built from Singapore for SG/MY deployment. The operating model combines structured biomarker logic, AI-assisted processing, privacy-aware workflows, and quality-controlled dashboard delivery.
Scaling Roadmap
From controlled launch delivery to global digital delivery.
Exia Bio is designed to begin with controlled launch-stage operations, then expand automation, partner workflows, and continuity tracking as product evidence accumulates.
Launch stage
Manual review and controlled release help protect quality while workflows are validated.
Automation stage
AI-assisted structuring, rule checks, and dashboard generation can be progressively automated.
Scale stage
The same workflow can support regional product pages, partner channels, and continuity-based tracking.